Occlutech GmbH notched a win in its long-running patent war with St. Jude Medical (NYSE:STJ) over structural heart implants, saying an Italian court ruled that it doesn’t infringe a portion of a St. Jude patent.
St. Jude inherited the case, involving intravascular occlusion devices, after it acquired AGA Medical for more than $1 billion last year.
Each side has logged victories since the case first hit German courts in 2006, with Jena, Germany-based Occlutech eventually coming out on top in a ruling by the German Supreme Court in May. St. Jude slapped Occlutech and Peters with another set of lawsuits the next month.
"We have spent years developing and patenting our unique technology," CEO Tor Peters said in prepared remarks. "We are convinced that when applied in cardiac occluders and many other minimally invasive implants it is a big step forward offering patients significant advantages."
Last month Peters was at the center of another win against St. Jude, when a personal lawsuit against him was dismissed by a German court. At the time Peters called the suit "amazing and quite shocking."